Airani Sathananthan

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Common Genetic Variation in <i>GLP1R</i> and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects

Airani Sathananthan, Chiara Dalla Man, Francesco Micheletto et al. · Diabetes Care · 2010 · 129 citations · Full text

Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes

Minette Lagman, Judy Ly, Tommy Saing et al. · PLoS ONE · 2015 · 106 citations · Full text

Human Growth, Immunodeficiencies, Immune Regulation +27

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis

Garrett Teskey, Ruoqiong Cao, Hicret Islamoglu et al. · Frontiers in Immunology · 2018 · 53 citations · Full text

Antibiotic Adjuvant, Immunology, Antimicrobial Chemotherapy +18

Late‐night salivary cortisol for diagnosis of Cushing’s syndrome by liquid chromatography/tandem mass spectrometry assay

Dana Erickson, Ravinder Singh, Airani Sathananthan et al. · Clinical Endocrinology · 2011 · 50 citations